OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Alzheimer disease in African American individuals: increased incidence or not enough data?
Lisa L. Barnes
Nature Reviews Neurology (2021) Vol. 18, Iss. 1, pp. 56-62
Open Access | Times Cited: 107
Lisa L. Barnes
Nature Reviews Neurology (2021) Vol. 18, Iss. 1, pp. 56-62
Open Access | Times Cited: 107
Showing 1-25 of 107 citing articles:
2023 Alzheimer's disease facts and figures
Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 2072
Alzheimer s & Dementia (2023) Vol. 19, Iss. 4, pp. 1598-1695
Open Access | Times Cited: 2072
2024 Alzheimer's disease facts and figures
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 628
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3708-3821
Open Access | Times Cited: 628
Effect of Race on Prediction of Brain Amyloidosis by Plasma Aβ42/Aβ40, Phosphorylated Tau, and Neurofilament Light
Suzanne E. Schindler, Thomas K. Karikari, Nicholas J. Ashton, et al.
Neurology (2022) Vol. 99, Iss. 3
Open Access | Times Cited: 109
Suzanne E. Schindler, Thomas K. Karikari, Nicholas J. Ashton, et al.
Neurology (2022) Vol. 99, Iss. 3
Open Access | Times Cited: 109
Insights into Alzheimer’s disease from single-cell genomic approaches
Mitchell H. Murdock, Li‐Huei Tsai
Nature Neuroscience (2023) Vol. 26, Iss. 2, pp. 181-195
Open Access | Times Cited: 101
Mitchell H. Murdock, Li‐Huei Tsai
Nature Neuroscience (2023) Vol. 26, Iss. 2, pp. 181-195
Open Access | Times Cited: 101
Alzheimer disease blood biomarkers: considerations for population-level use
Michelle M. Mielke, Nicole R. Fowler
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 495-504
Closed Access | Times Cited: 26
Michelle M. Mielke, Nicole R. Fowler
Nature Reviews Neurology (2024) Vol. 20, Iss. 8, pp. 495-504
Closed Access | Times Cited: 26
Physical exercise, cognition, and brain health in aging
Nárlon Cássio Boa Sorte Silva, Cindy K. Barha, Kirk I. Erickson, et al.
Trends in Neurosciences (2024)
Closed Access | Times Cited: 23
Nárlon Cássio Boa Sorte Silva, Cindy K. Barha, Kirk I. Erickson, et al.
Trends in Neurosciences (2024)
Closed Access | Times Cited: 23
2025 Alzheimer's disease facts and figures
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access | Times Cited: 3
Alzheimer s & Dementia (2025) Vol. 21, Iss. 4
Open Access | Times Cited: 3
African ancestry GWAS of dementia in a large military cohort identifies significant risk loci
Richard Sherva, Rui Zhang, Nathan Sahelijo, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1293-1302
Open Access | Times Cited: 47
Richard Sherva, Rui Zhang, Nathan Sahelijo, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 3, pp. 1293-1302
Open Access | Times Cited: 47
Quantification of race/ethnicity representation in Alzheimer’s disease neuroimaging research in the USA: a systematic review
Aaron C. Lim, Lisa L. Barnes, Gali H. Weissberger, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 35
Aaron C. Lim, Lisa L. Barnes, Gali H. Weissberger, et al.
Communications Medicine (2023) Vol. 3, Iss. 1
Open Access | Times Cited: 35
Alzheimer’s disease: a mini-review for the clinician
Rishi S. Madnani
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 25
Rishi S. Madnani
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 25
Do microbes play a role in Alzheimer's disease?
Zoë Williams, Léonie Láng, Sarah Nicolas, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 10
Zoë Williams, Léonie Láng, Sarah Nicolas, et al.
Microbial Biotechnology (2024) Vol. 17, Iss. 4
Open Access | Times Cited: 10
“I don’t see anything specifically about Black/African Americans.” Testing an Alzheimer-specific generative AI tool tailored for African American/Black communities
Cristina Bosco, Fereshtehossadat Shojaei, Alec Andrew Theisz, et al.
ACM Transactions on Computing for Healthcare (2025)
Closed Access | Times Cited: 1
Cristina Bosco, Fereshtehossadat Shojaei, Alec Andrew Theisz, et al.
ACM Transactions on Computing for Healthcare (2025)
Closed Access | Times Cited: 1
The Social Vulnerability Index and Incidence of Alzheimer Disease in a Population-Based Sample of Older Adults
Pankaja Desai, Jerenda Bond, Anisa Dhana, et al.
Neurology (2025) Vol. 104, Iss. 8
Closed Access | Times Cited: 1
Pankaja Desai, Jerenda Bond, Anisa Dhana, et al.
Neurology (2025) Vol. 104, Iss. 8
Closed Access | Times Cited: 1
Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: A longitudinal study of dementia-free older adults
Inaara Ebrahim, Maryam Ghahremani, Richard Camicioli, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 9-18
Open Access | Times Cited: 22
Inaara Ebrahim, Maryam Ghahremani, Richard Camicioli, et al.
Journal of Affective Disorders (2023) Vol. 332, pp. 9-18
Open Access | Times Cited: 22
Association of Early Adulthood Hypertension and Blood Pressure Change With Late-Life Neuroimaging Biomarkers
Kristen M. George, Pauline Maillard, Paola Gilsanz, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e236431-e236431
Open Access | Times Cited: 21
Kristen M. George, Pauline Maillard, Paola Gilsanz, et al.
JAMA Network Open (2023) Vol. 6, Iss. 4, pp. e236431-e236431
Open Access | Times Cited: 21
Expanding the scope of health disparities research in Alzheimer's disease and related dementias
Igor Akushevich, Julia Kravchenko, Arseniy Yashkin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Igor Akushevich, Julia Kravchenko, Arseniy Yashkin, et al.
Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 18
Longitudinal amyloid and tau PET imaging in Alzheimer's disease: A systematic review of methodologies and factors affecting quantification
Ariane Bollack, Hugh Pemberton, Lyduine E. Collij, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5232-5252
Open Access | Times Cited: 18
Ariane Bollack, Hugh Pemberton, Lyduine E. Collij, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 11, pp. 5232-5252
Open Access | Times Cited: 18
Direct and Indirect Effects of Socioeconomic Status and Discrimination on Subjective Cognitive Decline: A Longitudinal Study of African American Women
Ronald L. Simons, Mei Ling Ong, Steven R. H. Beach, et al.
The Journals of Gerontology Series B (2023) Vol. 78, Iss. 5, pp. 799-808
Open Access | Times Cited: 17
Ronald L. Simons, Mei Ling Ong, Steven R. H. Beach, et al.
The Journals of Gerontology Series B (2023) Vol. 78, Iss. 5, pp. 799-808
Open Access | Times Cited: 17
Racial discrimination during middle age predicts higher serum phosphorylated tau and neurofilament light chain levels a decade later: A study of aging black Americans
Ronald L. Simons, Mei Ling Ong, Man‐Kit Lei, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3485-3494
Open Access | Times Cited: 8
Ronald L. Simons, Mei Ling Ong, Man‐Kit Lei, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 5, pp. 3485-3494
Open Access | Times Cited: 8
Assessing Culturally Tailored Dementia Interventions to Support Informal Caregivers of People Living with Dementia (PLWD): A Scoping Review
Araya Dimtsu Assfaw, Kerstin M. Reinschmidt, Thomas A. Teasdale, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access | Times Cited: 7
Araya Dimtsu Assfaw, Kerstin M. Reinschmidt, Thomas A. Teasdale, et al.
Journal of Racial and Ethnic Health Disparities (2024)
Closed Access | Times Cited: 7
Racial and ethnic differences in plasma biomarker eligibility for a preclinical Alzheimer's disease trial
Doris P. Molina‐Henry, Rema Raman, Andy Liu, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 3827-3838
Open Access | Times Cited: 6
Doris P. Molina‐Henry, Rema Raman, Andy Liu, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 6, pp. 3827-3838
Open Access | Times Cited: 6
Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues
Bibhuti Bhusan Kakoti, Rajashri Bezbaruah, Nasima Ahmed
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Bibhuti Bhusan Kakoti, Rajashri Bezbaruah, Nasima Ahmed
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Brain-Derived Neurotrophic Factor: A Connecting Link Between Nutrition, Lifestyle, and Alzheimer’s Disease
Bin Xue, Shah Mohammad Abbas Waseem, Zhixin Zhu, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Bin Xue, Shah Mohammad Abbas Waseem, Zhixin Zhu, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 26
Characterizing Plasma Biomarkers of Alzheimer's in a Diverse Community-Based Cohort: A Cross-Sectional Study of the HAB-HD Cohort
James Hall, Melissa Petersen, Leigh Johnson, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 26
James Hall, Melissa Petersen, Leigh Johnson, et al.
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 26
Blood Tests for Alzheimer’s Disease: Increasing Efforts to Expand and Diversify Research Participation Is Critical for Widespread Validation and Acceptance
Thomas K. Karikari
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 3, pp. 967-974
Open Access | Times Cited: 24
Thomas K. Karikari
Journal of Alzheimer s Disease (2022) Vol. 90, Iss. 3, pp. 967-974
Open Access | Times Cited: 24
